VCM
DSGN icon

Versant Capital Management’s Design Therapeutics DSGN Stock Holding History

Versant Capital Management’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24K Buy
+86
New +$1.07K ﹤0.01% 2619
2025
Q4 		– Sell
-71
Closed -$535 – 2669
2025
Q3 		$535 Buy
+71
New +$356 ﹤0.01% 2564

Other funds holding DSGN

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Versant Capital Management's DSGN Position: Q2 2026 in Review

Versant Capital Management opened a new position in Design Therapeutics (DSGN) in Q2 2026: 86 shares worth $1.24K. The stake represents ﹤0.01% of the portfolio and ranks #2619 among its holdings. This is a return to the name: Versant Capital Management previously reported a position in DSGN as recently as Q3 2025.

Versant Capital Management first reported a position in DSGN in Q3 2025 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Versant Capital Management held 86 shares of Design Therapeutics worth $1.24K as of Q2 2026.
  • Design Therapeutics was a new Versant Capital Management position in Q2 2026.
  • Design Therapeutics made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2619 holding.
  • Versant Capital Management first reported a position in Design Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.